# PASS-01 (NCT04469556)

> Pancreatic Adenocarcinoma Signature Stratification for Treatment

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04469556
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: University Health Network, Toronto
- Conditions: Pancreatic Cancer Metastatic; Pancreatic Ductal Adenocarcinoma; Advanced Pancreatic Cancer
- Interventions: Folfirinox; Gemcitabine/nab-paclitaxel
- Enrollment: 150
- Primary outcome: Progression free survival(PFS) in mFFX and GA arms pancreatic ductal adenocarcinoma (PDAC) in a randomized phase II trial.

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 23
- Podcasts: 3
- YouTube: 1

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=pass-01-nct04469556

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04469556", "email": "<work email>"}; the inbox owner confirms by the emailed link.